Pelthos Therapeutics, Inc. (PTHS)
31.00
+3.51
(+12.77%)
USD |
NYAM |
Dec 31, 16:00
31.20
+0.20
(+0.65%)
Pre-Market: 20:00
Pelthos Therapeutics EPS Diluted (Quarterly): -5.304 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ligand Pharmaceuticals, Inc. | 5.685 |
| Agenus, Inc. | 1.944 |
| Travere Therapeutics, Inc. | 0.2505 |
| Inhibrx Biosciences, Inc. | -2.278 |
| Palvella Therapeutics, Inc. | -1.025 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.24M |
| Revenue (Quarterly) | 7.406M |
| Total Expenses (Quarterly) | 23.64M |
| Enterprise Value | 9.675M |
| Gross Profit Margin (Quarterly) | 54.31% |
| Profit Margin (Quarterly) | -219.3% |
| Earnings Yield | -45.78% |
| Normalized Earnings Yield | -45.78 |